Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms GH Oliveira-Paula, R Lacchini, JE Tanus-Santos Gene 575 (2), 584-599, 2016 | 179 | 2016 |
Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases GH Oliveira-Paula, R Lacchini, JE Tanus-Santos Nitric Oxide 63, 39-51, 2017 | 81 | 2017 |
Inducible nitric oxide synthase as a possible target in hypertension G H Oliveira-Paula, R Lacchini, J E Tanus-Santos Current drug targets 15 (2), 164-174, 2014 | 78 | 2014 |
Pharmacogenomics and hypertension: current insights GH Oliveira-Paula, SC Pereira, JE Tanus-Santos, R Lacchini Pharmacogenomics and personalized medicine, 341-359, 2019 | 69 | 2019 |
Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population TM da Silva, AV Rocha, R Lacchini, CR Marques, ES Silva, ... Gene 502 (2), 142-146, 2012 | 69 | 2012 |
Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy ACT Palei, VC Sandrim, LM Amaral, JSR Machado, RC Cavalli, ... The pharmacogenomics journal 12 (6), 489-498, 2012 | 64 | 2012 |
eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril PS Silva, V Fontana, MR Luizon, R Lacchini, WA Silva, C Biagi, ... European journal of clinical pharmacology 69, 167-177, 2013 | 60 | 2013 |
Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy MR Luizon, VC Sandrim, ACT Palei, R Lacchini, RC Cavalli, G Duarte, ... Hypertension Research 35 (9), 917-921, 2012 | 54 | 2012 |
Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients R Lacchini, ALB Jacob-Ferreira, MR Luizon, S Gasparini, ... Journal of human hypertension 26 (3), 171-177, 2012 | 51 | 2012 |
Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients DAC Cusinato, R Lacchini, EA Romao, M Moysés‐Neto, EB Coelho British journal of clinical pharmacology 78 (2), 364-372, 2014 | 50 | 2014 |
Inducible nitric oxide synthase haplotype associated with migraine and aura T de OS Mansur, FM Gonçalves, A Martins-Oliveira, JG Speciali, F Dach, ... Molecular and Cellular Biochemistry 364, 303-308, 2012 | 50 | 2012 |
Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura FM Gonçalves, A Martins-Oliveira, R Lacchini, VA Belo, JG Speciali, ... Gene 512 (1), 35-40, 2013 | 48 | 2013 |
A pharmacogenetics‐based approach to reduce cardiovascular mortality with the prophylactic use of statins R Lacchini, PS Silva, JE Tanus‐Santos Basic & clinical pharmacology & toxicology 106 (5), 357-361, 2010 | 47 | 2010 |
Genetic biomarkers for differential diagnosis of major depressive disorder and bipolar disorder: a systematic and critical review IC Menezes, C von Werne Baes, R Lacchini, MF Juruena Behavioural brain research 357, 29-38, 2019 | 46 | 2019 |
Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy MR Luizon, ACT Palei, VC Sandrim, LM Amaral, JSR Machado, ... The pharmacogenomics journal 14 (6), 535-541, 2014 | 46 | 2014 |
Gene–gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy MR Luizon, ACT Palei, VA Belo, LM Amaral, R Lacchini, G Duarte, ... The pharmacogenomics journal 17 (5), 427-434, 2017 | 45 | 2017 |
ROS production by mitochondria: function or dysfunction? FR Palma, BN Gantner, MJ Sakiyama, C Kayzuka, S Shukla, R Lacchini, ... Oncogene 43 (5), 295-303, 2024 | 44 | 2024 |
Inducible nitric oxide synthase haplotype associated with hypertension and responsiveness to antihypertensive drug therapy GH Oliveira-Paula, R Lacchini, FB Coeli-Lacchini, HM Junior, ... Gene 515 (2), 391-395, 2013 | 44 | 2013 |
Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients R Lacchini, ALB Jacob-Ferreira, MR Luizon, FB Coeli, TC Izidoro-Toledo, ... Clinica chimica acta 411 (23-24), 1940-1944, 2010 | 42 | 2010 |
Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity VA Belo, MR Luizon, PC Carneiro, VA Gomes, R Lacchini, CMM Lanna, ... Molecular biology reports 40, 2697-2704, 2013 | 40 | 2013 |